BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fasae KD, Abolaji AO, Faloye TR, Odunsi AY, Oyetayo BO, Enya JI, Rotimi JA, Akinyemi RO, Whitworth AJ, Aschner M. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives. J Trace Elem Med Biol 2021;67:126779. [PMID: 34034029 DOI: 10.1016/j.jtemb.2021.126779] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Urbanowicz T, Hanć A, Olasińska-wiśniewska A, Rodzki M, Witkowska A, Michalak M, Perek B, Haneya A, Jemielity M. Serum copper concentration reflect inflammatory activation in the complex coronary artery disease – A pilot study. Journal of Trace Elements in Medicine and Biology 2022;74:127064. [DOI: 10.1016/j.jtemb.2022.127064] [Reference Citation Analysis]
2 Luo Y, Li H, Cai M, Liu Y, Chen L, Xu S, Bai G. Designing polyacrylic acid capped luminescent rare earth core-shell nanoparticles for simultaneous Cu(II) and temperature sensing. Materials & Design 2022. [DOI: 10.1016/j.matdes.2022.111405] [Reference Citation Analysis]
3 Chen L, Fan Y, Zhao L, Zhang Q, Wang Z. The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.106301] [Reference Citation Analysis]
4 Aalikhani M, Khalili M, Jahanshahi M. The natural iron chelators' ferulic acid and caffeic acid rescue mice's brains from side effects of iron overload. Front Neurol 2022;13:951725. [DOI: 10.3389/fneur.2022.951725] [Reference Citation Analysis]
5 Gonzalez P, Sabater L, Mathieu E, Faller P, Hureau C. Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer’s-Related Aβ Peptide. Biomolecules 2022;12:1327. [DOI: 10.3390/biom12101327] [Reference Citation Analysis]
6 Pal A, Cerchiaro G, Rani I, Ventriglia M, Rongioletti M, Longobardi A, Squitti R. Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities. Biomolecules 2022;12:1248. [DOI: 10.3390/biom12091248] [Reference Citation Analysis]
7 Islam F, Shohag S, Akhter S, Islam MR, Sultana S, Mitra S, Chandran D, Khandaker MU, Ashraf GM, Idris AM, Emran TB, Cavalu S. Exposure of metal toxicity in Alzheimer’s disease: An extensive review. Front Pharmacol 2022;13:903099. [DOI: 10.3389/fphar.2022.903099] [Reference Citation Analysis]
8 Tyler SEB, Tyler LDK. Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer's disease. Nat Prod Bioprospect 2022;12:34. [PMID: 35996065 DOI: 10.1007/s13659-022-00354-z] [Reference Citation Analysis]
9 Bortolami M, Pandolfi F, Tudino V, Messore A, Madia VN, De Vita D, Di Santo R, Costi R, Romeo I, Alcaro S, Colone M, Stringaro A, Espargaró A, Sabatè R, Scipione L. Design, Synthesis, and In Vitro, In Silico and In Cellulo Evaluation of New Pyrimidine and Pyridine Amide and Carbamate Derivatives as Multi-Functional Cholinesterase Inhibitors. Pharmaceuticals 2022;15:673. [DOI: 10.3390/ph15060673] [Reference Citation Analysis]
10 Dusek P, Hofer T, Alexander J, Roos PM, Aaseth JO. Cerebral Iron Deposition in Neurodegeneration. Biomolecules 2022;12:714. [DOI: 10.3390/biom12050714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
11 Lampinen R, Górová V, Avesani S, Liddell JR, Penttilä E, Závodná T, Krejčík Z, Lehtola JM, Saari T, Kalapudas J, Hannonen S, Löppönen H, Topinka J, Koivisto AM, White AR, Giugno R, Kanninen KM. Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer's Disease Patients. Int J Mol Sci 2022;23:4123. [PMID: 35456941 DOI: 10.3390/ijms23084123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Mancuso C. The brain heme oxygenase/biliverdin reductase system as a target in drug research and development. Expert Opin Ther Targets 2022;:1-14. [PMID: 35285395 DOI: 10.1080/14728222.2022.2052848] [Reference Citation Analysis]
13 John OO, Amarachi IS, Chinazom AP, Adaeze E, Kale MB, Umare MD, Upaganlawar AB. Phytotherapy: A promising approach for the treatment of Alzheimer's disease. Pharmacological Research - Modern Chinese Medicine 2022;2:100030. [DOI: 10.1016/j.prmcm.2021.100030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lai C, Chen Z, Ding Y, Chen Q, Su S, Liu H, Ni R, Tang Z. Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways. Front Immunol 2022;13:782434. [DOI: 10.3389/fimmu.2022.782434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Ren B, Guo C, Liu RZ, Bian ZY, Liu RC, Huang LF, Tang JJ. Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships. Eur J Med Chem 2022;228:114031. [PMID: 34875520 DOI: 10.1016/j.ejmech.2021.114031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Prachayasittikul V, Pingaew R, Prachayasittikul S, Prachayasittikul V. 8-Hydroxyquinolines: A Promising Pharmacophore Potentially Developed as Disease-Modifying Agents for Neurodegenerative Diseases: A Review. HETEROCYCLES 2022;105:202. [DOI: 10.3987/rev-22-sr(r)6] [Reference Citation Analysis]
17 Uraguchi S, Nagai K, Naruse F, Otsuka Y, Ohshiro Y, Nakamura R, Takanezawa Y, Kiyono M. Development of affinity bead-based in vitro metal-ligand binding assay reveals dominant cadmium affinity of thiol-rich small peptides phytochelatins beyond glutathione. Metallomics 2021;13:mfab068. [PMID: 34850059 DOI: 10.1093/mtomcs/mfab068] [Reference Citation Analysis]
18 Lai C, Ding Y, Chen Q, Su S, Liu H, Ni R, Tang Z. Rapamycin attenuated zinc-induced tau phosphorylation and oxidative stress in animal model: Involvement of dual mTOR/p70S6K and Nrf2/HO-1 pathways.. [DOI: 10.1101/2021.09.24.461637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang XQ, Zhou LY, Tan RX, Liang GP, Fang SX, Li W, Xie M, Wen YH, Wu JQ, Chen YP. Design, Synthesis, and Evaluation of Chalcone Derivatives as Multifunctional Agents against Alzheimer's Disease. Chem Biodivers 2021;18:e2100341. [PMID: 34510699 DOI: 10.1002/cbdv.202100341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bisogno T, Lauritano A, Piscitelli F. The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota. Life (Basel) 2021;11:934. [PMID: 34575083 DOI: 10.3390/life11090934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Uraguchi S, Nagai K, Naruse F, Otsuka Y, Ohshiro Y, Nakamura R, Takanezawa Y, Kiyono M. Development of affinity beads-based in vitro metal-ligand binding assay reveals dominant cadmium affinity of thiol-rich small peptides phytochelatins beyond glutathione.. [DOI: 10.1101/2021.08.23.456032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]